These results suggest that enhancing SIRT2 activity is beneficial for obesity-related disease, such as type 2 diabetes mellitus, nonalcoholic fatty liver, and metabolic syndrome. This evidence concerns the gene SIRT2 and obesity due to melanocortin 4 receptor deficiency.